They work in complex ways that were still learning about
GLP-1 prescribing specialists routinely evaluate patients for liraglutide-based therapy, and consulting a Saxenda doctor within this practice ensures that appropriate candidates receive the most clinically suitable GLP-1 agent for their specific metabolic and behavioral profile
What is the difference between FDA-approved brand-name drugs and compounded GLP-1 medications
Two studies reported a significant reduction in lower limb amputations (LLA) and diabetic foot ulcers, while one study found no significant difference in LLA compared to other diabetic therapies
Study findings The study cohort consisted of 36,082 and 234,028 GLP-1 receptor agonist and DPP-4 inhibitor users, respectively, who were followed for a median of 1.3 and 1.7 years
however, this reflects the early stage of research in this field